Gefitinib for epidermal growth factor receptor mutant lung cancers:: Searching for a weapon of mass destruction

被引：5
作者：
Jaenne, Pasi A. [1 ]
机构：
[1] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 21期
关键词：
D O I：
10.1200/JCO.2006.06.6555
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3319 / 3321
页数：3
相关论文
共 22 条
[1]  
Amann J, 2005, CANCER RES, V65, P226
[2]   Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients [J].
Cappuzzo, F ;
Varella-Garcia, M ;
Shigematsu, H ;
Domenichini, I ;
Bartolini, S ;
Ceresoli, GL ;
Rossi, E ;
Ludovini, V ;
Gregorc, V ;
Toschi, L ;
Franklin, WA ;
Crino, L ;
Gazdar, AF ;
Bunn, RA ;
Hirsch, FR .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) :5007-5018
[3]   Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer [J].
Cappuzzo, F ;
Hirsch, FR ;
Rossi, E ;
Bartolini, S ;
Ceresoli, GL ;
Bemis, L ;
Haney, J ;
Witta, S ;
Danenberg, K ;
Domenichini, I ;
Ludovini, V ;
Magrini, E ;
Gregorc, V ;
Doglioni, C ;
Sidoni, A ;
Tonato, M ;
Franklin, WA ;
Crino, L ;
Bunn, PA ;
Varella-Garcia, M .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (09) :643-655
[4]   Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer [J].
Chou, TY ;
Chiu, CH ;
Li, LH ;
Hsiao, CY ;
Tzen, CY ;
Chang, KT ;
Chen, YM ;
Perng, RP ;
Tsai, SF ;
Tsai, CM .
CLINICAL CANCER RESEARCH, 2005, 11 (10) :3750-3757
[5]   Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients [J].
Cortes-Funes, H ;
Gomez, C ;
Rosell, R ;
Valero, P ;
Garcia-Giron, C ;
Velasco, A ;
Izquierdo, A ;
Diz, P ;
Camps, C ;
Castellanos, D ;
Alberola, V ;
Cardenal, F ;
Gonzalez-Larriba, JL ;
Vieitez, JM ;
Maeztu, I ;
Sanchez, JJ ;
Queralt, C ;
Mayo, C ;
Mendez, P ;
Moran, T ;
Taron, M .
ANNALS OF ONCOLOGY, 2005, 16 (07) :1081-1086
[6]   ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines [J].
Engelman, JA ;
Jänne, PA ;
Mermel, C ;
Pearlberg, J ;
Mukohara, T ;
Fleet, C ;
Cichowski, K ;
Johnson, BE ;
Cantley, LC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (10) :3788-3793
[7]   High expression of ErbB family members and their ligands in lung adenocarcinomas that are sensitive to inhibition of epidermal growth factor receptor [J].
Fujimoto, N ;
Wislez, M ;
Zhang, J ;
Iwanaga, K ;
Dackor, J ;
Hanna, AE ;
Kalyankrishna, S ;
Cody, DD ;
Price, RE ;
Sato, M ;
Shay, JW ;
Minna, JD ;
Peyton, M ;
Tang, XM ;
Massarelli, E ;
Herbst, R ;
Threadgill, DW ;
Wistuba, II ;
Kurie, JM .
CANCER RESEARCH, 2005, 65 (24) :11478-11485
[8]   Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib [J].
Han, SW ;
Kim, TY ;
Hwang, PG ;
Jeong, S ;
Kim, J ;
Choi, IS ;
Oh, DY ;
Kim, LH ;
Kim, DW ;
Chung, DH ;
Im, SA ;
Kim, YT ;
Lee, JS ;
Heo, DS ;
Bang, YJ ;
Kim, NK .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (11) :2493-2501
[9]   Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: A Southwest Oncology Group Study [J].
Hirsch, FR ;
Varella-Garcia, M ;
McCoy, J ;
West, H ;
Xavier, AC ;
Gumerlock, P ;
Bunn, PA ;
Franklin, WA ;
Crowley, J ;
Gandara, DR .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) :6838-6845
[10]   High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan [J].
Huang, SF ;
Liu, HP ;
Li, LH ;
Ku, YC ;
Fu, YN ;
Tsai, HY ;
Chen, YT ;
Lin, YF ;
Chang, WC ;
Kuo, HP ;
Wu, YC ;
Chen, YR ;
Tsai, SF .
CLINICAL CANCER RESEARCH, 2004, 10 (24) :8195-8203
123